Effective control of chronic pain is a top priority in the United States, as approximately 10% of adults have severe chronic pain, most of which is chronic lower back pain (CLBP). However, despite the advances in neuroscience over the past 20 years, chronic pain is largely treated with opiate narcotics. In addition to their high abuse liability and dependence potential (1), only 30-40% of chronic pain patients declare they receive satisfactory (>50%) relief from their pain through pharmacological treatment. This clinical trial is researching the use of TMS as a potential novel, non-medication therapy for chronic lower back pain.
Interested in relieving chronic lower back pain? Please contact us.
Alcohol Use Disorder (AUD) is prevalent, devastating, and difficult to treat. The majority of the therapeutic approaches available to date have relied on pharmaceutical modulation or and/or psychotherapy. With a growing knowledge of the neural circuits that contribute to relapse in AUD, there is an emerging interest in developing a novel, neural-circuit specific therapeutic tool to enhance AUD treatment outcomes. Our lab currently has two clinical trials researching the use of TMS as an innovative treatment option for individuals with AUD: a multi-day study as well as a single-day study.
Interested in cutting back alcohol consumption? Please contact us.
Cigarette smoking constitutes the greatest preventable cause of mortality and morbidity in the US. Prior research indicates that the most critical period for long term success of smoking cessation appears to be in the first 7 days after the quit date. This clinical trial is researching the use of TMS as a potential novel, non-medication therapy to help facilitate quitting cigarette smoking during the critical 7 day period.
Interested in quitting cigarettes? Please contact us.